Published in Mol Autism on January 05, 2017
Clinical and Immunological Investigations of Subtypes of Autism | NCT00298246
Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ (2014) 11.24
Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature (2011) 10.16
Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol (2005) 5.95
Innate immunity in the central nervous system. J Clin Invest (2012) 2.77
The neurobiology of autism. Brain Pathol (2007) 2.63
Cytokines and T-cell homeostasis. Curr Opin Immunol (2007) 2.58
A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci (2007) 2.54
Elevated immune response in the brain of autistic patients. J Neuroimmunol (2009) 2.46
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci (2008) 2.00
Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta (2001) 1.99
The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol (2011) 1.96
Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity (2009) 1.95
Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics (2009) 1.75
Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol (1999) 1.66
Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol (2015) 1.62
Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol Biomarkers Prev (2011) 1.60
Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol (2007) 1.56
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem (2011) 1.40
The immune system and developmental programming of brain and behavior. Front Neuroendocrinol (2012) 1.36
Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care (2010) 1.36
Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun (2014) 1.25
Behavioral consequences of congenital rubella. J Pediatr (1978) 1.23
Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry (2014) 1.17
Autism and environmental genomics. Neurotoxicology (2006) 1.15
Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci (2015) 1.13
How cytokines co-occur across asthma patients: from bipartite network analysis to a molecular-based classification. J Biomed Inform (2011) 1.12
Roles of microglia in brain development, tissue maintenance and repair. Brain (2015) 1.12
A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Comput Biol (2010) 1.07
Cytokines in disease. Clin Chem (1990) 1.07
In search of cellular immunophenotypes in the blood of children with autism. PLoS One (2011) 1.04
Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Infect Immun (2011) 1.02
Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res (2013) 1.01
Frequency of CD4+CD25high regulatory T cells in the peripheral blood of Egyptian children with autism. J Child Neurol (2009) 1.01
Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells. Mol Biol Cell (2011) 0.99
Recurrence rates provide evidence for sex-differential, familial genetic liability for autism spectrum disorders in multiplex families and twins. Mol Autism (2015) 0.98
Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Glia (2008) 0.98
The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain. Front Cell Neurosci (2013) 0.97
Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. Cancer Epidemiol Biomarkers Prev (2013) 0.95
Evidence supporting an altered immune response in ASD. Immunol Lett (2014) 0.94
Neuroinflammation: Ways in Which the Immune System Affects the Brain. Neurotherapeutics (2015) 0.93
SNP analyses of growth factor genes EGF, TGFbeta-1, and HGF reveal haplotypic association of EGF with autism. Biochem Biophys Res Commun (2007) 0.92
Febrile illness and pro-inflammatory cytokines are associated with lower neurodevelopmental scores in Bangladeshi infants living in poverty. BMC Pediatr (2014) 0.92
Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.92
Plasma cytokine levels in children with autistic disorder and unrelated siblings. Int J Dev Neurosci (2011) 0.90
Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents (2013) 0.89
Mouse model of intrauterine inflammation: sex-specific differences in long-term neurologic and immune sequelae. Brain Behav Immun (2014) 0.88
Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation (2012) 0.87
CD40 and vascular inflammation. Can J Cardiol (2004) 0.86
Brain interleukin-15 in neuroinflammation and behavior. Neurosci Biobehav Rev (2012) 0.85
Autism spectrum disorders: from immunity to behavior. Methods Mol Biol (2012) 0.85
Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage. Cancer Causes Control (2014) 0.85
Increased serum levels of epidermal growth factor in children with autism. J Autism Dev Disord (2011) 0.83
Decreased levels of EGF in plasma of children with autism spectrum disorder. Autism Res Treat (2012) 0.83
Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease. Neurosci Lett (2008) 0.83
A pilot open-label trial of minocycline in patients with autism and regressive features. J Neurodev Disord (2013) 0.82
Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism. Biomark Insights (2013) 0.81
Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls. Schizophr Res (2015) 0.80
Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J Neuroinflammation (2013) 0.80
Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability. J Neuroimmunol (2012) 0.80
Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol (2011) 0.80
Immune Endophenotypes in Children with Autism Spectrum Disorder. Biol Psychiatry (2015) 0.80
Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J Neurovirol (2014) 0.79
Increased plasma chemokine levels in children with Prader-Willi syndrome. Am J Med Genet A (2015) 0.79
Genetic research in autism spectrum disorders. Curr Opin Pediatr (2015) 0.78
Developmental changes in soluble CD40 ligand. J Pediatr (2007) 0.76
Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective. CNS Neurol Disord Drug Targets (2016) 0.76